Supplementary Data
Supplementary Figure 1 | Ibipinabant-induced mitochondrial dysfunction is not linked to decreased respiratory capacity or direct inhibition of respiratory chain complexes. (A) Basal respiratory rates were determined after 4 hours of incubation with increasing ibipinabant concentrations. Data are expressed as percentage of vehicle (33±2 pmolO 2 /s/10 6 cells). Next to recording of basal respiratory rates, digitonin was added to the chambers of the respirometer to permeabilise the cells for measurement of (B) complex (C)I-, CII-, CIII-, and CIV-driven oxygen consumption. The data presented are expressed as percentage of vehicle-treated control (pmolO 2 /s/10 6 cells): 81±4 for CI, 92±4 for CII, 47±3 for CIII, 262±12 for CIV. (C) After 4 hours exposure of C2C12 myoblasts to increasing ibipinabant concentrations a mitochondrial-enriched fraction was prepared and freeze-thawed for permeabilisation of the mitochondrial membranes. The fractions were resuspended in the assay medium and the catalytic capacity of CI, CII, CIII, CIV, and CV was measured. The data presented are expressed as percentage of vehicle control: 190±30 mU/U CS for CI, 204±10 mU/U CS for CII, 560±30 mU/U CS for CIII, 360±40 mU/U CS for CIV, and 350±30 mU/U COX for CV. Statistical analysis: one-way ANOVA with Dunnett's post hoc analysis was applied to compare values to vehicle control, no statistically significant differences could be observed. Mean ± SEM; n=3 independent experiments.
